SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksConvaTec Regulatory News (CTEC)

Share Price Information for ConvaTec (CTEC)

Share Price is delayed by 15 minutes
Get Live Data
202.60    2.60 (1.30%)
Bid:
203.20
Ask:
203.60
Spread: 0.40 (0.197%)
Market Cap: £3.96b
CTEC Live PriceLast checked at - London Stock Exchange

Intraday ConvaTec Share Chart

Director/PDMR Shareholding

17 Mar 2022 14:40

RNS Number : 1733F
ConvaTec Group PLC
17 March 2022
 

Reading, United Kingdom - Thursday 17 March 2022

 

ConvaTec Group Plc("ConvaTec" or "the Company")Director/PDMR Shareholding

The Company has been notified of the following transactions by Persons Discharging Managerial Responsibility ("PDMR") in ordinary shares of 10 pence each in the share capital of the Company ("Shares").

On 14 March 2022, Karim Bitar, the Company's Chief Executive Officer, and Jonny Mason, the Company's Chief Financial Officer, both Executive Directors, were granted conditional share awards under the Company's Long Term Incentive Plan (LTIP), subject to a time vesting period of three years, performance conditions based on a combination of Adjusted Profit Before Tax growth and Total Shareholder Return, and continued employment, as follows:

Karim Bitar: 1,238,337Jonny Mason: 690,112

Further, on the same day, Karim Bitar was granted 263,650 Shares in accordance with the Company's remuneration policy approved by shareholders, as a result of one third of Mr Bitar's annual bonus being paid out as deferred shares, such shares to vest on the third anniversary of grant. The three-day average share price, closing on 11 March 2022 of 181.13 pence was used in determining the number of shares to be granted under the deferred bonus provisions.

The attached notification, made in accordance with the requirements of the EU Market Abuse Regulation, gives further detail.

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Karim Bitar

2

Reason for the notification

a)

Position/Status

Chief Executive Officer

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

ConvaTec Group Plc

b)

LEI

213800LS272L4FIDOH92

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 10p each in ConvaTec Group Plc ("Shares")

GB00BD3VFW73

b)

Nature of the transaction

1. Grant of conditional share award under the ConvaTec Group Plc Long Term Incentive Plan subject to (i) time vesting period of three years, (ii) performance conditions based on a combination of Adjusted Profit Before Tax growth and Total Shareholder Return and (ii) continued employment

2. Grant of restricted share award under the deferred bonus provisions, subject only to a time-based vesting period of three years.

 

c)

Price(s) and volume(s)

Price(s)

1 - n/a

2 - n/a

Volume(s)

1 - 1,238,337

2 - 263,650

d)

Aggregated information

- Aggregated volume

- Price

 

n/a

n/a

e)

Date of the transaction

2022-03-14

f)

Place of the transaction

Outside a trading venue

 

 

 

 

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Jonny Mason

2

Reason for the notification

a)

Position/Status

Chief Financial Officer

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

ConvaTec Group Plc

b)

LEI

213800LS272L4FIDOH92

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 10p each in ConvaTec Group Plc ("Shares")

GB00BD3VFW73

b)

Nature of the transaction

Grant of conditional share award under the ConvaTec Group Plc Long Term Incentive Plan subject to (i) time vesting period of three years, (ii) performance conditions based on a combination of Adjusted Profit Before Tax growth and Total Shareholder Return and (ii) continued employment.

 

c)

Price(s) and volume(s)

Price(s)

n/a

Volume(s)

690,112

d)

Aggregated information

- Aggregated volume

- Price

 

n/a

n/a

e)

Date of the transaction

2022-03-14

f)

Place of the transaction

Outside a trading venue

 

 

 

 

 

 

Enquiries

Analysts and Investors

Kate Postans, VP Investor Relations, ConvaTec +44 (0)782 644 7807

ir@convatec.com

 

Media

Buchanan: Charles Ryland / Chris Lane   +44 (0)207 466 5000

ConvaTec Group Plc's LEI code is 213800LS272L4FIDOH92

About ConvaTec

ConvaTec is a global medical products and technologies company focused on solutions for the management of chronic conditions, with leading market positions in advanced wound care, ostomy care, continence and critical care, and infusion care. Our products provide a range of clinical and economic benefits including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care. To learn more about ConvaTec, please visit www.convatecgroup.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFLFVSVIIDLIF
Date   Source Headline
30th Nov 20203:45 pmRNSDirector/PDMR Shareholding
2nd Nov 20202:30 pmRNSTotal Voting Rights
30th Oct 202010:40 amRNSHolding(s) in Company
28th Oct 20207:00 amRNSQ3 Trading Update
20th Oct 20204:05 pmRNSDirector/PDMR Shareholding
19th Oct 20203:30 pmRNSDirector/PDMR Shareholding
12th Oct 20202:00 pmRNSHolding(s) in Company
7th Oct 202011:50 amRNSDirector Declaration
5th Oct 20206:35 pmRNSHolding(s) in Company
29th Sep 20202:05 pmRNSScrip Dividend - Total Issued Shares
10th Sep 20201:00 pmRNSScrip Dividend - Calculation Price
28th Aug 20203:54 pmRNSDirector/PDMR Shareholding
28th Aug 20203:42 pmRNSDirector/PDMR Shareholding
11th Aug 20209:40 amRNSHolding(s) in Company
6th Aug 20207:00 amRNSInterim Results
13th Jul 202011:00 amRNSNon-Executive Director appointment
30th Jun 20207:00 amRNSBoard Committee Changes
10th Jun 202010:00 amRNSHolding(s) in Company
1st Jun 202010:45 amRNSTotal Voting Rights
29th May 202010:00 amRNSBoard Change
19th May 202010:40 amRNSDirector/PDMR Shareholding
19th May 202010:35 amRNSDirector/PDMR Shareholding
18th May 20204:30 pmRNSHolding(s) in Company
14th May 202010:45 amRNSHolding(s) in Company
11th May 20204:10 pmRNSNon-Executive Director appointment
7th May 20204:15 pmRNSResult of AGM
5th May 20202:15 pmRNSDirector/PDMR Shareholding
30th Apr 20207:00 amRNSConvaTec Group Plc Q1 2020 Trading Update
28th Apr 20202:20 pmRNSScrip Dividend - Total Issued Shares
22nd Apr 20207:00 amRNSHolding(s) in Company
9th Apr 202012:30 pmRNSScrip Dividend - Calculation Price
3rd Apr 202011:00 amRNSDirector Declaration
2nd Apr 202012:45 pmRNSAnnual General Meeting Update
24th Mar 20202:20 pmRNSDirector Declaration
16th Mar 20203:40 pmRNS2019 Annual Report & Accounts and Notice of AGM
13th Mar 202011:05 amRNSDirector/PDMR Shareholding
13th Mar 202011:00 amRNSDirector/PDMR Shareholding
11th Mar 20203:50 pmRNSDirector/PDMR Shareholding
11th Mar 20203:45 pmRNSDirector/PDMR Shareholding
28th Feb 20207:00 amRNSPreliminary Results
27th Feb 202011:00 amRNSNon-Executive Director appointment
10th Jan 202012:45 pmRNSDirector/PDMR Shareholding
7th Nov 20192:00 pmRNSUpdate Statement following AGM Voting Outcome
1st Nov 201911:30 amRNSTotal Voting Rights
30th Oct 20197:00 amRNSQ3 Trading Update
21st Oct 20194:50 pmRNSDirector/PDMR Shareholding
21st Oct 20193:45 pmRNSHolding(s) in Company
14th Oct 20193:30 pmRNSDirector/PDMR Shareholding
4th Oct 20197:30 amRNSDirector/PDMR Shareholding
27th Sep 20194:44 pmRNSScrip Dividend - Total Issued Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.